X0508 4 2026-01-07 0000862692 CRYO CELL INTERNATIONAL INC CCEL 0001544572 Mikulinsky Oleg 700 BROOKER CREEK BLVD SUITE 1800 OLDSMAR FL 34677 false true false false Chief Information Officer false Common Stock 104349 D Stock Option 7.49 2018-05-21 2028-05-21 Common Stock 8000 8000 D Stock Option 7.13 2019-09-04 2029-09-04 Common Stock 4444 4444 D Stock Option 6.55 2020-02-27 2030-02-27 Common Stock 1333 1333 D Stock Option 8 2021-09-23 2028-09-23 Common Stock 10000 10000 D Stock Option 11.9 2021-12-28 2028-12-28 Common Stock 20000 20000 D Stock Option 5.88 2023-12-22 2028-12-22 Common Stock 10000 10000 D Stock Option 7.35 2025-01-21 2030-01-21 Common Stock 10000 10000 D Stock Option 3.54 2026-01-07 4 A false 10000 3.54 A 2026-01-07 2031-01-07 Common Stock 10000 10000 D Stock Option 3.54 2026-01-07 4 A false 20000 3.54 A 2026-01-07 2031-01-07 Common Stock 20000 20000 D Stock options vest 1/5 per year commencing on September 23, 2021. Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven year option period. Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027. Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. /s/ Oleg Mikulinsky 2026-01-09